Search by Drug Name or NDC
NDC 65628-0206-05 FIRVANQ Details
FIRVANQ
FIRVANQ is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc. The primary component is .
MedlinePlus Drug Summary
Vancomycin is used to treat colitis (inflammation of the intestine caused by certain bacteria) that may occur after antibiotic treatment. Vancomycin is in a class of medications called glycopeptide antibiotics. It works by killling bacteria in the intestines. Vancomycin will not kill bacteria or treat infections in any other part of the body when taken by mouth. Antibiotics such as vancomycin will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 65628-0206-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Vancomycin
Product Information
NDC | 65628-0206 |
---|---|
Product ID | 65628-206_0c018d41-1802-4500-e063-6394a90a2ef2 |
Associated GPIs | 16280080102170 |
GCN Sequence Number | 009333 |
GCN Sequence Number Description | vancomycin HCl SOLN RECON 50 MG/ML ORAL |
HIC3 | W1J |
HIC3 Description | VANCOMYCIN ANTIBIOTICS AND DERIVATIVES |
GCN | 41291 |
HICL Sequence Number | 004042 |
HICL Sequence Number Description | VANCOMYCIN HCL |
Brand/Generic | Brand |
Proprietary Name | FIRVANQ |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | vancomycin hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Azurity Pharmaceuticals, Inc |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA208910 |
Listing Certified Through | 2024-12-31 |
Package
NDC 65628-0206-05 (65628020605)
NDC Package Code | 65628-206-05 |
---|---|
Billing NDC | 65628020605 |
Package | 1 KIT in 1 CARTON (65628-206-05) * 7.5 g in 1 BOTTLE * 145 mL in 1 BOTTLE |
Marketing Start Date | 2018-01-26 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.94002 |
Pricing Unit | ML |
Effective Date | 2022-10-01 |
NDC Description | FIRVANQ 50 MG/ML SOLUTION |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4, 5 |
Classification for Rate Setting | B |
As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis